Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boosting Regional Integration for COPD Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle: A Multicentre , Prospective, Cluster Randomization, Inteventional Clinical Study

NCT06646419 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06646419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06646419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boosting Regional Integration for COPD Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle: A Multicentre , Prospective, Cluster Randomization, Inteventional Clinical Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 13, 2024
Completion date
September 21, 2026
Enrollment
1,368 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

copd